Pharmacological evaluation of portal venous isolation and charcoal haemoperfusion for high-dose intra-arterial chemotherapy of the pancreas

British Journal of Surgery

Volumn 84, Issue 8, 1997, Pages 1072-1076

  Tominaga, M ^a   Ku, Y ^a   Iwasaki, T ^a   Suzuki, Y ^a   Kuroda, Y ^a   Saitoh, Y ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ARTICLE; CANCER CHEMOTHERAPY; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG TISSUE LEVEL; FEMALE; INTRAARTERIAL DRUG ADMINISTRATION; ISOLATED LIVER; MALE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; TECHNIQUE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHARCOAL; DOGS; DOXORUBICIN; FEMALE; HEMOPERFUSION; INFUSIONS, INTRA-ARTERIAL; LIVER; MALE; MYOCARDIUM; PANCREAS; PANCREATIC NEOPLASMS; PORTAL VEIN;

EID: 0030851274     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840809     Document Type: Article

References (30)

1. Warshaw AL, Fernandez del Castillo C. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-65.
2. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987; 59: 2006-10.
3. Mohiuddin M, Regine WF, Stevens J et al. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol 1995; 13: 2764-8.
4. Shipley WU, Wood WC, Tepper JE et al. Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma. Ann Surg 1984; 200: 289-96.
5. Roldan GE, Gunderson LL, Nagorney DM et al. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 1988; 61: 1110-16.
6. Carter SK, Comis RL. The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma. Cancer Treat Rev 1975; 2: 193-214.
7. Crown J, Casper ES, Botet J et al. Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenomacarcinoma. J Clin Oncol 1991; 9: 1682-6.
8. Schein PS, Lavin PT, Moertel CG et al. Randomized phase II clinical trial of Adriamyein, methotrexate, and actinomycin D in advanced measurable pancreatic carcinoma. A Gastrointestinal Tumor Study Group report. Cancer 1978; 42: 19-22,
9. Loehrer PJ Sr, Williams SD, Einhorn LH, Ansari K. Ifosfamide, an active drug in the treatment of adenocarcinoma of the pancreas. J Clin Oncol 1985; 3: 367-72.
10. Wils J, Bleiberg H, Blijham G et. al. Phase II study of epirubicin in advanced adenocarcinoma of the pancreas. Eur J Cancer Clin Oncol 1985; 21: 191-4.
11. Harvey JH, Schein PS. Chemotherapy of pancreatic carcinoma. World J Surg 1984; 8: 935-9.
12. Oster MW, Gray R, Panasci L, Perry MC. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, Adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM). Cancer 1986; 57: 29-33.
13. Yokoyama T, Shimada Y. Chemotherapy for advanced pancreatic carcinoma. Gan To Kagaku Ryoho 1992; 19: 2338-43.
14. Miura K, Hatta Y, Sasa T, Endo Y. Chemotherapy for pancreatic cancer. A combination of intra-arterial infusion chemotherapy and hyperthermia. Naika 1988; 62: 270-6.
15. Ishikawa O, Ohhigashi H, Iwanaga T. Intra-arterial infusion chemotherapy for non-resectable pancreatic cancer using angiotensin-11 and prostaglandin-El. Gan To Kagaku Ryoho 1985; 12: 235-44.
16. Arredondo MA, Chaudhuri B, Kar R, Crist KA, Thomford NR, Chaudhuri PK. Isolated perfusion of pancreas with mitomycin C. Am J Surg 1940; 159: 569-74.
17. Lord Smith of Marlow, Gazet JC. Intra-arterial chemotherapy for patients with inoperable carcinoma of the pancreas. Ann R Coll Surg Engl 1980; 62: 208-12.
18. McCracken JD, Olsen M, Cruz AB. Radiation therapy combined with intra-arterial 5-FU chemotherapy for treatment of localized adenocarcinoma of the pancreas; a Southwest Oncology Group study. Cancer Treat Rep 1982; 66: 549-51.
19. Theodors A, Bukowski RM, Hewlett JS, Livingston RB, Weick JK. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study. Am J Clin Oncol 1982; 5: 555-8.
20. Hafstrom L, Ihse I, Jonsson PE, Lunderquist A, Stridbeck H. Intraarterial 5-FU infusion with or without oral testolactone treatment in irresectable pancreatic cancer. Acta Chirurgica Scandinavica 1980; 146: 445-8.
21. Pierce RN, Jatlow PI. Measurement of Adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection. J Chromatogr 1979; 164: 471-8.
22. Kunimura T, Morohoshi T, Sato M et al. Histological evaluation of intra-arterial infusion and systemic chemotherapy for pancreatic carcinomas. Gan To Kagaku Ryoho 1992; 19: 355-60.
23. Kamidono S, Fujii A, Hamami G et al. New preoperative chemotherapy for bladder cancer using combination hemodialysis and direct hemoperfusion: preliminary report. J Urol 1984; 131: 36-40.
24. Agishi T, Nakazawa H, Teraoka S et al. Intraarterial bolus infusion followed by rapid removal of anticancer agents with hemocarboperfusion under local hyperthermia for advanced hepatic cancer. Gan To Kagaku Ryoho 1986; 13: 1611-17.
25. Takahashi Y, Hisajima S, Itoh Y. A clinical trial of the intraarterial infusion of CDDP in heavy dose with simultaneous hemodialysis, direct hemoperfusion and plasmapheresis. Japanese Journal of Clinical Urology 1985; 39: 433-6.
26. Ku Y, Saitoh M, Nishiyama H et al. Extracorporeal removal of anticancer drugs in hepatic artery infusion: the effect of direct hemoperfusion combined with venovenous bypass. Surgery 1990; 107: 273-81.
27. Ku Y, Fukumoto T, Iwasaki T et al. Clinical pilot study on high-dose intraarterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma. Surgery 1995; 117: 510-19.
28. Beheshti MV, Denny DF Jr, Glickman MG et al. Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report. J Vasc Interv Radiol 1992; 3: 453-8.
29. Curley SA, Byrd DR, New-man RA et al. Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration: a feasibility study of a novel system. Anticancer Drugs 1991; 2: 175-83.
30. Curley SA, Byrd DR, Newman RA et al. Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration. Surgery 1993; 114: 579-85.